People: Intra-Cellular Therapies Inc (ITCI.OQ)

ITCI.OQ on NASDAQ Stock Exchange Global Select Market

23 Aug 2019
Change (% chg)

$-0.18 (-2.08%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Hineline, Lawrence 

Mr. Lawrence J. Hineline CPA is the Chief Financial Officer, Senior Vice President - Finance, Treasurer, Assistant Secretary of Intra-Cellular Therapies, Inc. Mr. Hineline has served as Senior Vice President of Finance of the Company since January 2019 and Chief Financial Officer and Treasurer of the Company since the Merger in August 2013. He also served as Vice President of Finance of the Company from the Merger in August 2013 to December 2018. He has served as Vice President of Finance, Chief Financial Officer and Secretary of ITI since June 2002. Mr. Hineline also served as the Secretary of the Company from August 2013 until September 2014. From December 2000 to November 2003, Mr. Hineline was the Vice President of Finance and Chief Financial Officer of Functional Genetics, Inc. Prior to that, Mr. Hineline served as the Vice President of Finance of North American Vaccine, Inc. and its predecessor companies from 1993 to 2000, and he served as Corporate Controller from 1989 to 1993. During this time, Mr. Hineline oversaw the growth of the accounting function and its systems for the company that emerged as a start-up and was later acquired by Baxter Health Care. Mr. Hineline is a licensed CPA in the State of Maryland and received his Bachelor’s Degree from the University of Maryland Baltimore County.

Basic Compensation

Total Annual Compensation, USD 628,100
Restricted Stock Award, USD 749,986
Long-Term Incentive Plans, USD --
All Other, USD 749,722
Fiscal Year Total, USD 2,127,810

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised 37,500 560,376.00
Name Fiscal Year Total

Lawrence Hineline


Michael Halstead


Mark Neumann


Andrew Satlin


Robert Davis


John Bardi

As Of  31 Dec 2018